Skip to main content
. 2007 Feb;13(2):236–242. doi: 10.3201/eid1302.060781

Table 1. Patients with healthcare-associated MRSA isolates, 1999–2004, and predictors of SCCmec type IV phenotype*.

Characteristic Patients with HA-MRSA
Isolates, % (no.) SCCmec phenotype,% (no.)
Predictors of SCCmec type IV phenotype
Bivariate anaylsis
Multivariate analysis
Type IV Type II/III Odds ratio
(95% CI) p value Odds ratio (95% CI) p value
Total
(352)
36 (128)
64 (224)




Sex
F
35 (123)
36 (44)
64 (79)

0.87
>0.05
M
65 (229)
37 (84)
63 (145)


Age, y
Mean
50 ± 19 SD
47±1.7 SE
51±1.3 SE
0.02
>0.05
Median (range)
50 (<1–97)
48 (<1–87)
54 (<1–97)




Time from admission to specimen collection, d
Mean
19 ± 21 SD
15±1.9 SE
21±1.4 SE
0.01
0.88 (0.8–0.98)†
0.02
Median (range)
12 (4–184)
8 (4–174)
15 (4–184)




Culture specimen source
Blood
10 (35)
46 (16)
54 (19)
2.6 (1.2–5.7) 0.02
2.2 (0.97–5.0) 0.058
Sputum
34 (188)
25 (29)
75 (89)
Reference
Reference
Wound
38 (133)
49 (65)
51 (68)
2.9 (1.7–5.0) <0.0001
2.6 (1.5–4.6) 0.001
Other
19 (66)
27 (18)
73 (48)
1.2 (0.6–2.3)
0.69
1.1 (0.5–2.2)
0.82
Year culture specimen collected
1999
52 (15)
17 (9)
83 (43)
Reference
<0.0001‡
Reference
<0.0001
2000
57 (16)
19 (11)
81 (46)
1.1 (0.4–3.0)

NS§
2001
65 (19)
28 (18)
72 (47)
1.8 (0.7–4.5)
1.8 (0.9–3.7)
2002
47 (13)
43 (20)
57 (27)
3.5 (1.4–8.9]
3.2 (1.5–6.9)
2003
63 (18)
56 (35)
44 (28)
6.0 (2.4–14.3)
5.2 (2.5–10.5)
2004 68 (19) 52 (35) 48(33) 5.1 (2.1–12) 4.4 (2.2–8.8)

*MRSA, methicillin-resistant Staphylococcus aureus; HA, healthcare associated; CI, confidence interval; SD, standard deviation; SE, standard error; NS, not significant; boldface indicates significance.
†Multivariate analysis results reflect time in weeks.
‡Measured with the Cochran-Armitage test of trends.
§Was not a significant predictor in the multivariate model.